Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Baptist Health South Florida
Baptist Health South Florida
M.D. Anderson Cancer Center
Royal Marsden NHS Foundation Trust
City of Hope Medical Center
Canadian Cancer Trials Group
NRG Oncology
Massachusetts General Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Oklahoma
M.D. Anderson Cancer Center
GT Medical Technologies, Inc.
Memorial Sloan Kettering Cancer Center
Henry Ford Health System
City of Hope Medical Center
NRG Oncology
Grupo Español Multidisciplinar de Melanoma
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Radiation Therapy Oncology Group
Roswell Park Cancer Institute
GT Medical Technologies, Inc.
Emory University
National Medical Research Radiological Centre of the Ministry of Health of Russia
Soonchunhyang University Hospital
University of Sao Paulo
National Cancer Institute, Naples
National Cancer Institute, Naples
Elsan
Universitaire Ziekenhuizen KU Leuven
Cancer Research Antwerp
City of Hope Medical Center
Elisabeth-TweeSteden Ziekenhuis
Eastern Cooperative Oncology Group
California Pacific Medical Center Research Institute
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Istituto Clinico Humanitas
University of Texas Southwestern Medical Center
The Cooper Health System
Xi'an Jiaotong University
University of Texas Southwestern Medical Center
Dana-Farber Cancer Institute
Rigshospitalet, Denmark
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University Health Network, Toronto